PriceTargets.com logo

Primary Health Properties - PHP Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: GBX 102
  • Forecasted Upside: 11.05%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 91.85 As of 04/19/2024 05:35 PM ET
▲ +0.3 (0.33%)

This chart shows the closing price for PHP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Primary Health Properties Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHP

Analyst Price Target is GBX 102
▲ +11.05% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Primary Health Properties in the last 3 months. The average price target is GBX 102, with a high forecast of GBX 105 and a low forecast of GBX 98. The average price target represents a 11.05% upside from the last price of GBX 91.85.

This chart shows the closing price for PHP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Primary Health Properties. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/1/2024JPMorgan Chase & Co.Initiated CoverageNeutralGBX 105
2/9/2024Berenberg BankReiterated RatingBuyGBX 103
5/25/2023BarclaysLower TargetUnderweightGBX 100 ➝ GBX 98
2/27/2023Berenberg BankLower TargetHoldGBX 165 ➝ GBX 125
12/1/2022BarclaysDowngradeUnderweightGBX 150 ➝ GBX 105
8/31/2022Berenberg BankLower TargetHoldGBX 170 ➝ GBX 165
7/4/2022BarclaysLower TargetOverweightGBX 160 ➝ GBX 140
5/23/2022BarclaysReiterated RatingOverweightGBX 160
5/6/2022BarclaysReiterated RatingOverweightGBX 160
4/19/2022BarclaysReiterated RatingOverweightGBX 160
4/1/2022BarclaysReiterated RatingOverweightGBX 160
3/31/2022Berenberg BankReiterated RatingHoldGBX 170
3/21/2022BarclaysReiterated RatingOverweightGBX 160
3/8/2022BarclaysReiterated RatingOverweightGBX 156
2/15/2022BarclaysReiterated RatingOverweightGBX 164
2/11/2022Peel HuntReiterated RatingBuyGBX 175
2/3/2022BarclaysReiterated RatingOverweightGBX 164
1/24/2022BarclaysReiterated RatingOverweightGBX 164
12/8/2021Liberum CapitalReiterated RatingHoldGBX 176
11/24/2021Liberum CapitalReiterated RatingHold
10/29/2021BarclaysReiterated RatingOverweightGBX 164
10/28/2021Peel HuntReiterated RatingBuyGBX 175
10/28/2021Peel HuntReiterated RatingBuyGBX 175
8/4/2021Berenberg BankBoost TargetHoldGBX 160 ➝ GBX 170
8/3/2021Liberum CapitalDowngradeHoldGBX 170 ➝ GBX 176
7/28/2021Liberum CapitalReiterated RatingBuyGBX 170
5/12/2021Numis SecuritiesReiterated RatingAddGBX 184
5/12/2021Liberum CapitalReiterated RatingBuy
2/17/2021Jefferies Financial GroupBoost TargetBuyGBX 168 ➝ GBX 172
7/29/2020Peel HuntReiterated RatingAdd
7/29/2020Liberum CapitalReiterated RatingBuy
7/14/2020Berenberg BankDowngradeHoldGBX 150 ➝ GBX 155
7/9/2020Liberum CapitalReiterated RatingBuy
7/9/2020Peel HuntReiterated RatingRestricted
5/28/2020Peel HuntReiterated RatingAdd
5/11/2020Liberum CapitalReiterated RatingBuy
5/6/2020Berenberg BankReiterated RatingBuy
5/6/2020Peel HuntBoost TargetAddGBX 160 ➝ GBX 175
4/15/2020Peel HuntReiterated RatingAdd
4/15/2020BarclaysReiterated RatingOverweightGBX 168 ➝ GBX 170
4/2/2020Jefferies Financial GroupUpgradeBuyGBX 165 ➝ GBX 179
4/1/2020Peel HuntReiterated RatingAdd
4/1/2020Liberum CapitalReiterated RatingBuy
3/25/2020Berenberg BankUpgradeBuy
3/18/2020Peel HuntReiterated RatingAdd
3/12/2020Peel HuntReiterated RatingAdd
2/13/2020BarclaysReiterated RatingOverweightGBX 160 ➝ GBX 168
2/12/2020Peel HuntReiterated RatingAddGBX 160
2/12/2020Liberum CapitalReiterated RatingBuy
2/11/2020Peel HuntReiterated RatingAddGBX 160
2/5/2020Peel HuntReiterated RatingAdd
2/5/2020Liberum CapitalReiterated RatingBuy
1/27/2020Liberum CapitalUpgradeBuyGBX 130 ➝ GBX 185
1/17/2020Jefferies Financial GroupDowngradeHoldGBX 147 ➝ GBX 155
1/14/2020Peel HuntReiterated RatingAdd
1/7/2020Peel HuntReiterated RatingAdd
12/17/2019Peel HuntBoost TargetAddGBX 145 ➝ GBX 160
12/13/2019Jefferies Financial GroupReiterated RatingBuy
12/6/2019Liberum CapitalReiterated RatingHold
12/3/2019BarclaysInitiated CoverageOverweightGBX 160
12/3/2019Peel HuntReiterated RatingAdd
11/29/2019Berenberg BankInitiated CoverageHoldGBX 150
11/26/2019Peel HuntReiterated RatingAdd
11/25/2019Liberum CapitalReiterated RatingHold
11/5/2019Peel HuntReiterated RatingAdd
10/22/2019Peel HuntReiterated RatingAdd
10/15/2019Peel HuntReiterated RatingAdd
10/7/2019Peel HuntReiterated RatingAdd
9/26/2019Peel HuntReiterated RatingAdd
9/24/2019Liberum CapitalReiterated RatingHold
9/17/2019Peel HuntReiterated RatingAdd
9/10/2019Peel HuntReiterated RatingAdd
8/27/2019Peel HuntReiterated RatingAdd
8/20/2019Liberum CapitalReiterated RatingHold
8/9/2019Peel HuntReiterated RatingAdd
7/25/2019Liberum CapitalReiterated RatingHold
7/22/2019Peel HuntReiterated RatingAdd
7/15/2019Peel HuntReiterated RatingAdd
7/9/2019Peel HuntReiterated RatingAdd
6/25/2019Peel HuntReiterated RatingAdd
6/17/2019Peel HuntDowngradeAddGBX 140 ➝ GBX 145
6/11/2019Peel HuntReiterated RatingBuy
6/4/2019Peel HuntReiterated RatingBuy
5/28/2019Peel HuntReiterated RatingBuy
5/14/2019Peel HuntUpgradeBuy
5/8/2019Peel HuntUpgradeBuy
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.89 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
3/20/2024
  • 5 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 5 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Primary Health Properties logo
Primary Health Properties (PHP) is the leading investor in modern healthcare properties in the UK & Ireland. PHP is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP achieve this by investing in healthcare real estate let on long-term leases, backed by a secure underlying covenant funded mostly by government bodies. The Group's portfolio comprises over 480 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.
Read More

Today's Range

Now: GBX 91.85
Low: 90.75
High: 92.15

50 Day Range

MA: GBX 91.75
Low: 88.50
High: 95.35

52 Week Range

Now: GBX 91.85
Low: 84.20
High: 109

Volume

1,906,137 shs

Average Volume

3,254,273 shs

Market Capitalization

£1.23 billion

P/E Ratio

4,592.50

Dividend Yield

7.26%

Beta

0.34

Frequently Asked Questions

What sell-side analysts currently cover shares of Primary Health Properties?

The following Wall Street analysts have issued research reports on Primary Health Properties in the last year: Barclays PLC, Berenberg Bank, and JPMorgan Chase & Co..
View the latest analyst ratings for PHP.

What is the current price target for Primary Health Properties?

3 Wall Street analysts have set twelve-month price targets for Primary Health Properties in the last year. Their average twelve-month price target is GBX 102, suggesting a possible upside of 11.1%. JPMorgan Chase & Co. has the highest price target set, predicting PHP will reach GBX 105 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of GBX 98 for Primary Health Properties in the next year.
View the latest price targets for PHP.

What is the current consensus analyst rating for Primary Health Properties?

Primary Health Properties currently has 1 sell rating, 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PHP, but not buy more shares or sell existing shares.
View the latest ratings for PHP.

What other companies compete with Primary Health Properties?

Other companies that are similar to Primary Health Properties include Assura, Target Healthcare REIT, Impact Healthcare REIT, St. Modwen Properties and Sirius Real Estate. Learn More about companies similar to Primary Health Properties.

How do I contact Primary Health Properties' investor relations team?

Primary Health Properties' physical mailing address is 5th Fl, Greener House, 66-68 Haymarket, LONDON, SW1Y 4RF, United Kingdom. The real estate investment trust's listed phone number is +44-20-71045599. The official website for Primary Health Properties is www.phpgroup.co.uk. Learn More about contacing Primary Health Properties investor relations.